Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202755014 | Acetaminophen + propoxyphene napsylate 650mg/100mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215610011 | Acetaminophen + propoxyphene napsylate 650mg/100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478794013 | Acetaminophen+propoxyphene napsylate 650mg/100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2154786010 | Paracetamol + propoxyphene napsylate 650mg/100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3470034016 | Product containing acetaminophen 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3470035015 | Product containing paracetamol 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490490012 | Product containing paracetamol 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501706013 | Acetaminophen 650 mg and propoxyphene napsylate 100 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3501707016 | Paracetamol 650 mg and propoxyphene napsylate 100 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569353016 | Product containing only paracetamol 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569354010 | Product containing only acetaminophen 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569355011 | Product containing only paracetamol 650 mg and propoxyphene napsylate 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681761015 | Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681762010 | Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681763017 | Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 105048301000001119 | Paracetamol + propoxyphene napsylate 650mg/100mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing dextropropoxyphene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Opiate agonist (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol and propoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with opioid receptor agonist mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 650 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 650 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has precise active ingredient | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing dextropropoxyphene and paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 650 milligram/1 each conventional release oral tablet | Is a | Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR